Estrogen: a novel therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations.
about
Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1Estrogen receptor hormone agonists limit trauma hemorrhage shock-induced gut and lung injury in rats.The role of estrogen and receptor agonists in maintaining organ function after trauma-hemorrhage.Estrogen suppresses cardiac IL-6 after trauma-hemorrhage via a hypoxia-inducible factor 1 alpha-mediated pathway.Mitochondrial targeting by dichloroacetate improves outcome following hemorrhagic shock.Estrogenic hormone modulation abrogates changes in red blood cell deformability and neutrophil activation in trauma hemorrhagic shock.Aging influences cardiac mitochondrial gene expression and cardiovascular function following hemorrhage injury.Anti-HMGB1 monoclonal antibody ameliorates immunosuppression after peripheral tissue trauma: attenuated T-lymphocyte response and increased splenic CD11b (+) Gr-1 (+) myeloid-derived suppressor cells require HMGB1.Influence of aging and hemorrhage injury on Sirt1 expression: possible role of myc-Sirt1 regulation in mitochondrial functionLife or death? A physiogenomic approach to understand individual variation in responses to hemorrhagic shock.Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry.Resveratrol Improves Survival and Prolongs Life Following Hemorrhagic ShockSex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke.Estradiol's salutary effects on keratinocytes following trauma-hemorrhage are mediated by estrogen receptor (ER)-alpha and ER-betaWhat's New in Critical Illness and Injury Science? Estrogen: Is it a new therapeutic paradigm for trauma-hemorrhagic shock?Activation of endoplasmic reticulum stress response following trauma-hemorrhagePathophysiology of the systemic inflammatory response after major accidental trauma.Resveratrol restores sirtuin 1 (SIRT1) activity and pyruvate dehydrogenase kinase 1 (PDK1) expression after hemorrhagic injury in a rat model.
P2860
Q28567865-75095981-A7DD-419E-9C16-006061D9EA36Q33535940-B47C4750-560A-4856-9539-F862ECB1BC2AQ33621715-3FA770D6-46BD-42F6-80D8-A45D7B99C823Q33621727-4C8AB2C8-8A09-4310-AD0D-FDDD301080E8Q33752927-1B9DF87F-D9A4-403B-A523-A34F5670F264Q34509088-58902AFF-F987-4F37-BA1A-BAF3D80A71F9Q35016943-15348E2C-8113-411C-A01F-1FE47B4F60EDQ35076030-378A279A-D55A-419C-BFE7-A96ECB92C3E6Q35163084-D8FE63AD-4703-4B44-A1B4-3BD6644159B5Q35228795-6AF5C280-9F13-4C60-90F7-EAD3B93F431AQ35552358-A9CF7C3A-5FE2-4453-97F1-E924A2570A90Q35855677-75865C88-5AC8-4A4B-8B2C-6792BA6E7CAFQ36185871-69B9E1B5-8F04-47A8-BEF1-AF1077795F44Q36856650-09661EB7-FCF2-4AAE-A44E-973B1E811201Q36991646-E1ABB30E-D846-4263-AA20-8842F6AEEB8EQ37066784-8DDF4412-553B-4B7D-A550-04AD3873574BQ37375163-E4841A70-2AD7-472F-ABEF-7F39D6BE4720Q37549574-2ECE5553-01F2-451A-8097-64F58C368C41
P2860
Estrogen: a novel therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Estrogen: a novel therapeutic ...... ced immunological alterations.
@ast
Estrogen: a novel therapeutic ...... ced immunological alterations.
@en
type
label
Estrogen: a novel therapeutic ...... ced immunological alterations.
@ast
Estrogen: a novel therapeutic ...... ced immunological alterations.
@en
prefLabel
Estrogen: a novel therapeutic ...... ced immunological alterations.
@ast
Estrogen: a novel therapeutic ...... ced immunological alterations.
@en
P2860
P356
P1433
P1476
Estrogen: a novel therapeutic ...... ced immunological alterations.
@en
P2093
Kirby I Bland
Raghavan Raju
P2860
P2888
P304
P356
10.2119/2008-00001.RAJU
P407
P577
2008-03-01T00:00:00Z
P6179
1068965067